-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Initiates Coverage On Amicus Therapeutics with Buy Rating, Announces Price Target of $17

Benzinga·12/17/2025 15:22:02
Listen to the news
Citigroup analyst Samantha Semenkow initiates coverage on Amicus Therapeutics (NASDAQ:FOLD) with a Buy rating and announces Price Target of $17.